How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Blood Collection Tubes (BCT) Market
- By Product Type: Vacuum Blood Collection Tubes, Non-Vacuum Blood Collection Tubes, Capillary Blood Collection Tubes, Specialty Blood Collection Tubes
- By Additive Type: EDTA Tubes, Sodium Citrate Tubes, Heparin Tubes, Serum Separator Tubes (SST), Fluoride Tubes, Plain Tubes (No Additive)
- By End User: Hospitals, Diagnostic Laboratories, Blood Banks, Research Institutes, Ambulatory Care Centers
- By Material Type: Plastic Blood Collection Tubes, Glass Blood Collection Tubes
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Vacuum Blood Collection Tubes leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 13 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 270 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.164 →
- 11 Company Profiles 13 players: SWOT & benchmarking p.172 →
Full report · locked preview
Everything inside the Blood Collection Tubes (BCT) Market report
A complete, evidence-based study - 11 chapters and 113 sections covering market size, segmentation across 4 axes, regional analysis and 13 company profiles, forecast to 2033.
Segmentation covered
Product Type 4
Additive Type 6
End User 5
Material Type 2
Companies profiled
Becton Dickinson and Company (BD)
Greiner Bio-One International GmbH
Terumo Corporation
Sarstedt AG & Co. KG
Sartorius AG
Nipro Corporation
Kangjian Medical Apparatus Co. Ltd.
Jiangsu Yuyue Medical Equipment & Supply Co. Ltd.
Ningbo Medical Needle Co. Ltd.
Ningbo Jianan Medical Instrument Co. Ltd.
Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
Hettich AG
+1 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
13 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Becton Dickinson and Company (BD)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Greiner Bio-One International GmbH
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Terumo Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Sarstedt AG & Co. KG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Sartorius AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Nipro Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.184 →Kangjian Medical Apparatus Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Jiangsu Yuyue Medical Equipment & Supply Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Ningbo Medical Needle Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Ningbo Jianan Medical Instrument Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.214 →Hettich AG
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →Vacuette (Greiner Bio-One)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →
Global · 2025–2033
$5,548M by 2033 · 8.5% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Vacuum Blood Collection Tubes43.3
- Non-Vacuum Blood Collection Tubes22.3
- Capillary Blood Collection Tubes17.9
- Specialty Blood Collection Tubes16.5
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$956.2M → $1,638M · 7.0%
Europe$666.5M → $1,326M · 9.0%
Asia Pacific$608.5M → $1,300M · 10.0%
Latin America$376.7M → $802.4M · 9.9%
Middle East and Africa$289.8M → $498.7M · 7.0%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →8.402026
8.412027
8.432028
8.432029
8.452030
8.462031
8.492032
8.492033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Becton Dickinson and Company (BD)22.4
- Greiner Bio-One International GmbH17.7
- Terumo Corporation8.6
- Sarstedt AG & Co. KG11.0
- Sartorius AG7.3
- Nipro Corporation5.1
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type26.9%
Additive Type26.0%
End User28.3%
Material Type18.7%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America29.4
- Europe23.8
- Asia Pacific23.4
- Latin America14.4
- Middle East and Africa9.0
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Becton Dickinson and Company (BD) | 74 | 87 | 86 | 85 | 90 | 80 | 84 |
| Greiner Bio-One International GmbH | 89 | 70 | 68 | 90 | 78 | 79 | 79 |
| Terumo Corporation | 73 | 72 | 85 | 82 | 80 | 69 | 77 |
| Sarstedt AG & Co. KG | 80 | 62 | 82 | 58 | 64 | 61 | 68 |
| Sartorius AG | 61 | 53 | 59 | 65 | 73 | 65 | 63 |
| Nipro Corporation | 64 | 47 | 56 | 53 | 52 | 67 | 57 |
| Kangjian Medical Apparatus Co. Ltd. | 64 | 44 | 48 | 48 | 52 | 43 | 50 |
| Jiangsu Yuyue Medical Equipment & Supply Co. Ltd. | 46 | 47 | 56 | 39 | 37 | 40 | 44 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Becton Dickinson and Company (BD)
- Greiner Bio-One International GmbH
- Terumo Corporation
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Becton Dickinson and Company (BD) | ✓ | ◐ | ✓ | ✓ | ✓ | ✓ |
| Greiner Bio-One International GmbH | ✓ | ◐ | ◐ | ✓ | ◐ | ◐ |
| Terumo Corporation | ◐ | ◐ | ✓ | ◐ | ◐ | ✓ |
| Sarstedt AG & Co. KG | ✓ | − | ◐ | − | − | ◐ |
| Sartorius AG | ◐ | − | − | ◐ | − | ◐ |
| Nipro Corporation | − | ◐ | − | ◐ | ◐ | ◐ |
| Kangjian Medical Apparatus Co. Ltd. | ◐ | ◐ | − | − | ◐ | − |
| Jiangsu Yuyue Medical Equipment & Supply Co. Ltd. | − | − | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Becton Dickinson and Company (BD)84
2Greiner Bio-One International GmbH79
3Terumo Corporation77
4Sarstedt AG & Co. KG68
5Sartorius AG63
6Nipro Corporation57
7Kangjian Medical Apparatus Co. Ltd.50
8Jiangsu Yuyue Medical Equipment & Supply Co. Ltd.44
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Becton Dickinson and Company (BD)Greiner Bio-One International GmbH
Challenger2
Strong scale, closing on the leaders.
Terumo CorporationSarstedt AG & Co. KG
Contender2
Focused players with pockets of strength.
Sartorius AGNipro Corporation
Niche2
Specialists in a single segment or region.
Kangjian Medical Apparatus Co. Ltd.Jiangsu Yuyue Medical Equipment & Supply Co. Ltd.
Go-to-market strategy
Land Product Type in North America, then scale across Blood Collection Tubes (BCT) Market — a $640M beachhead inside a $9.57B market.
Beachhead (SOM)$640Mobtainable near-term
Serviceable (SAM)$3.60Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Vacuum Blood Collection Tubes
Best fit — highest urgency & budget in Product Type.
Economic buyer77 fit
Non-Vacuum Blood Collection Tubes
Strong fit — clear ROI and a fast path to value.
End user66 fit
Capillary Blood Collection Tubes
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Additive Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales42%
Partner / channel29%
Digital / self-serve20%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Blood Collection Tubes (BCT) Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified46%
Sales qualified22%
Evaluation14%
Closed-won5%
$16.1KCAC
$89KLTV
5.5:1LTV : CAC
< 4 moCAC payback
Investment thesis
Blood Collection Tubes (BCT) Market is a durable-growth opportunity — $8.16B by 2033, compounding at 10.0%.
TAM · 2025$3.81Btoday
TAM · 2033$8.16Bforecast
CAGR10.0%2027–2033
Cumulative$51.7Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$8.16BTotal addressable market
SAM$3.07BServiceable available market
SOM$669MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →10.0% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
13+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$8.16BLarge & growingTAM by 2033 at 10.0% CAGR
$3.07BServiceable nowreachable with today’s model
$669MBeachhead winobtainable near-term share
13+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$6.37BBear6.5% CAGR
$8.16BBase10.0% CAGR
$10.4BBull13.2% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Additive Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Blood Collection Tubes (BCT) Market — a $1.62B market by 2033. Plan: grow share from 5.5% to 11.4%.
Market size · 2033$1.62Btotal addressable
Market CAGR11.6%2027–2033
Target share11.4%from 5.5% today
Revenue ambition$185Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 5.5% | 11.4% | At risk |
| Revenue | $90M | $185M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | Behind |
| Gross margin | 35.5% | 39.6% | Behind |
| Customer retention | 88.0% | 92.5% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Additive Type capability
A defensible second engine — invest in Additive Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Additive Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $18M capacity & capability investment
- Greenlight bolt-on M&A in Additive Type
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossAt risk
- Input-cost & supply riskAt risk
- Regulatory / policy changeAt risk
- Execution & talentOn track
Sales deck · value proposition
Win the Blood Collection Tubes (BCT) Market conversation — a $6.98B market you can size, segment and defend in minutes.
Market size · 2033$6.98Btotal opportunity
Growth7.0%CAGR to 2033
Addressable buyers1,535+accounts in scope
Typical ROI6.3×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.3×return on cost, year one
< 3 mopayback period
$75K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
13+players profiled in this market
Coverage includes
Becton Dickinson and Company (BD)Greiner Bio-One International GmbHTerumo CorporationSarstedt AG & Co. KGSartorius AGNipro CorporationKangjian Medical Apparatus Co. Ltd.Jiangsu Yuyue Medical Equipment & Supply Co. Ltd.+5 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Blood Collection Tubes (BCT) Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Blood Collection Tubes (BCT) Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Blood Collection Tubes and Vials Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportBlood Component Extractor Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportBlood Conservation Device Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportBlood Conversation System Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportBlood Culture Devices Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportBlood Culture Test Device Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportBlood Dialysis Water Treatment Equipment Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportBlood Disease Drugs Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportBlood Donation Market
Market size, share, segmentation and regional forecast.
$6.1B market · 2025 base year
View reportBlood Donor Armchairs Market
Market size, share, segmentation and regional forecast.
$1.0B market · 2025 base year
View reportBlood Electric Chair Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportBlood Factors Market
Market size, share, segmentation and regional forecast.
$416M market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report ships as a formatted PDF, a fully editable XLSX containing all underlying data tables, and a presentation-ready PPT deck - so you can re-chart, re-model, or drop any figure straight into your own deck.